Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Article in Nature Medicine (April 2024)
The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.
Article in Nature Medicine (April 2024)
Article in Carcinogenesis (February 2024)
Article in Current Topics in Medicinal Chemistry (January 2024)